Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Wiesel

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Biological Psychiatry|December 1, 1982
Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidityF A Wiesel, B Fyrö, H Nybäck, et al.
Synapse (New York, N.Y.)|August 15, 1998
Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390J Yu, H Coirini, L Källström, et al.
Psychopharmacology|January 1, 1988
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PETL Farde, F A Wiesel, P Jansson, et al.
Psychiatry Research|July 9, 1999
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controlsL Flyckt, O Sydow, L Bjerkenstedt, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patientsC Härnryd, L Bjerkenstedt, B Gullberg, et al.
Neuroreport|April 19, 1995
Neuroleptics differentially modulate central dopamine D1-receptor bindingA E Johnson, H Coirini, L Källström, et al.
Psychopharmacology Series|January 1, 1988
PET scanning--a new tool in clinical psychopharmacologyG Sedvall, L Farde, H Hall, et al.
Psychopharmacology|October 1, 1995
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patientsP Karlsson, L Smith, L Farde, et al.
Psychopharmacology|January 1, 1985
Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patientsL Bjerkenstedt, G Edman, L Flyckt, et al.
Archives of General Psychiatry|November 1, 2001
Aberrant tyrosine transport across the cell membrane in patients with schizophreniaL Flyckt, N Venizelos, G Edman, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Biological Psychiatry|December 1, 1982
Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidityF A Wiesel, B Fyrö, H Nybäck, et al.
Synapse (New York, N.Y.)|August 15, 1998
Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390J Yu, H Coirini, L Källström, et al.
Psychopharmacology|January 1, 1988
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PETL Farde, F A Wiesel, P Jansson, et al.
Psychiatry Research|July 9, 1999
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controlsL Flyckt, O Sydow, L Bjerkenstedt, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patientsC Härnryd, L Bjerkenstedt, B Gullberg, et al.
Neuroreport|April 19, 1995
Neuroleptics differentially modulate central dopamine D1-receptor bindingA E Johnson, H Coirini, L Källström, et al.
Psychopharmacology Series|January 1, 1988
PET scanning--a new tool in clinical psychopharmacologyG Sedvall, L Farde, H Hall, et al.
Psychopharmacology|October 1, 1995
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patientsP Karlsson, L Smith, L Farde, et al.
Psychopharmacology|January 1, 1985
Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patientsL Bjerkenstedt, G Edman, L Flyckt, et al.
Archives of General Psychiatry|November 1, 2001
Aberrant tyrosine transport across the cell membrane in patients with schizophreniaL Flyckt, N Venizelos, G Edman, et al.
Pageof 9